Clinical Trial Update: Azacytidine Prior to in Vivo T-cell Depleted Allo Stem Cell Transplant for Patients With Myeloid Malignancies in CR [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated azacytidine prior to in vivo T-cell depleted allogeneic stem cell transplant in patients with myeloid malignancies, and the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia Erythroblastic Acute
• Myelodysplastic Syndromes

Drugs mentioned

• azacytidine (azacitidine)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Leukemia, Erythroblastic, Acute, Myelodysplastic Syndromes | Phase 2 | Status: COMPLETED | Results posted: 2021-09-22